Cited by 15Cardiac Health and Mental HealthFatty Acid Research and HealthMetabolomics and Mass Spectrometry Studies

Novel Phospholipid Signature of Depressive Symptoms in Patients with Coronary Artery Disease

Open access
Chan, Parco, Suridjan, Ivonne, Mohammad, Dana, Herrmann, Nathan, Mazereeuw, Graham, Hillyer, Lyn M., Ma, David W. L., Oh, Paul I. +1 more·2018·Journal of the American Heart Association

Abstract

Background Depression in patients with coronary artery disease ( CAD ) is associated with increased cardiovascular morbidity. Given the proinflammatory actions of phospholipids, aberrant phospholipid metabolism may be an etiological mechanism linking CAD and depression. Our primary objective was to identify a phospholipid biomarker panel that characterizes CAD patients with significant depressive symptoms from those without. Methods and Results We performed a targeted lipidomic analysis on CAD patients with significant depressive symptoms (n=37, Center for Epidemiologic Studies Depression score ≥16) and those without (n=49). Phospholipid species were selected using partial least‐square discriminant analysis, and the ability of the resulting model to discriminate between groups was evaluated using receiver operator characteristic curves. Biosignature scores were calculated from this model, and analyses of covariance were performed to compare intergroup differences in biosignature scores, with adjustment for clinical differences between patients. Those with significant depressive symptoms had lower cardiopulmonary fitness, more prevalent history of depression, and a greater number of vascular risk factors. A model of 10 phospholipid species had an area under the curve value of 0.84 (95% confidence interval 0.72‐0.95), sensitivity of 0.73, and specificity of 0.71. This model passed permutation testing (n=1000, P <0.001). Biosignature scores were higher in those with significant depressive symptoms after adjustment for potential confounders (F[1.86]=14.39, P <0.0005). Conclusions The present findings support the role of proinflammatory phospholipid species in the presence of depression in CAD patients from the CAROTID trial (Coronary Artery Disease Randomized Omega‐3 Trial in Depression). Future investigations should aim to replicate findings in larger data sets and clarify possible pathophysiological mechanisms. Clinical Trial Registration URL : https://www.clinicaltrials.gov . Unique identifier: NCT 00981383.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/jaha.117.008278

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chan, P., Suridjan, I., Mohammad, D., Herrmann, N., Mazereeuw, G., Hillyer, L. M., Ma, D. W. L., Oh, P. I., & Lanctôt, K. L.
Affiliations
  • University of Toronto (CA)
  • Sunnybrook Hospital (CA)
  • University of Guelph (CA)
  • Department of Human Health and Nutritional Sciences, University of Guelph, Ontario, Canada
  • University Health Network (CA)
Corresponding author
Lanctôt, Krista L.
Venue
Journal of the American Heart Association
Published
2018-05-15
Volume
7
Issue
10
ISSN
2047-9980 (ISSN-L)
OpenAlex
W2802241866
Cited by
15
References
51
Citations by year
2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 1
FWCI
1.13
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Journal of the American Heart Association (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Canadian Institutes of Health Research (114913_1)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
depression, coronary artery disease, phospholipids, lipidomics, biomarkers, inflammation, depressive symptoms, cardiovascular risk, cardiorespiratory fitness, vascular risk factors, omega-3 fatty acids
MeSH terms
Affect, Aged, Aged, 80 and over, Coronary Artery Disease, Cross-Sectional Studies, Depression, Female, Humans, Male, Middle Aged, Phospholipids, Predictive Value of Tests, Risk Factors, Reproducibility of Results, Biomarkers, Case-Control Studies, Randomized Controlled Trials as Topic, Inflammation Mediators, Metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review